Publications by authors named "Johan Halse"

Claim this Profile
A
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.
Johan Halse, Susan Greenspan, Felicia Cosman, Graham Ellis, Arthur Santora

J Clin Endocrinol Metab· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Re: Medical findings in an interdisciplinary geriatric outpatient clinic specialising in falls].
Johan Halse

Tidsskr Nor Laegeforen· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[J. Halse replies].
Johan Halse

Tidsskr Nor Laegeforen· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Estrogen--a matter of the heart].
Johan Halse

Tidsskr Nor Laegeforen· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New developments in the treatment of osteoporosis.
Erik Fink Eriksen, Johan Halse, Mette Haase Moen

Acta Obstet Gynecol Scand· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[When should bisphosphonate treatment be discontinued?].
Erik Fink Eriksen, Johan Halse

Tidsskr Nor Laegeforen· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis.
Michael R McClung, Steven Boonen, Ove Törring, Christian Roux, René Rizzoli, Johan Halse

J Bone Miner Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Denosumab for treatment of postmenopausal osteoporosis].
Unni Syversen, Johan I Halse, Jürgen Geisler, Erik Fink Eriksen

Tidsskr Nor Laegeforen· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Osteoporosis patients are disfavorized by the subsidized prescription system].
Johan Halse

Tidsskr Nor Laegeforen· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Bisphosphonate treatment of osteoporosis and other skeletal diseases].
Unni Syversen, Johan I Halse

Tidsskr Nor Laegeforen· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of loss of regional fat assessed by DXA on insulin resistance and dyslipidaemia in obese men.
Gunnar Aasen, Hans Fagertun, Johan Halse

Scand J Clin Lab Invest· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of regional fat loss assessed by DXA on insulin resistance and dyslipidaemia in obese women.
Gunnar Aasen, Hans Fagertun, Johan Halse

Scand J Clin Lab Invest· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New proposal concerning alendronate reimbursement].
Johan Halse

Tidsskr Nor Laegeforen· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance and dyslipidaemia in obese premenopausal and postmenopausal women matched for leg/trunk fat mass ratio.
Gunnar Aasen, Hans Fagertun, Johan Halse

Scand J Clin Lab Invest· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men.
Gunnar Aasen, Hans Fagertun, Serena Tonstad, Johan Halse

Scand J Clin Lab Invest· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lean mass and fat mass on bone mineral density: The Hordaland Health Study.
Clara G Gjesdal, Johan I Halse, Geir Egil Eide, Johan G Brun, Grethe S Tell

Maturitas· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Robert R Recker, Pierre D Delmas, Johan Halse, Ian R Reid, Steven Boonen

J Bone Miner Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of osteoporosis with parathyroid hormone].
Unni Syversen, Johan I Halse

Tidsskr Nor Laegeforen· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Glitazones--again].
Johan Halse

Tidsskr Nor Laegeforen· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.
Matti J Välimäki, Jordi Farrerons-Minguella, Johan Halse, Heikki Kröger, Marilyn Maroni

Clin Ther· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Is there a need of glitazones in the treatment of diabetes?].
Johan Halse

Tidsskr Nor Laegeforen· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Nevertheless control of documentation of generic drugs?].
Johan Halse

Tidsskr Nor Laegeforen· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese.
Jean-Michel Gaullier, Johan Halse, Hans Olav Høivik, Kjetil Høye, Christian Syvertsen

Br J Nutr· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment.
Richard Prince, Adrien Sipos, Anwar Hossain, Unni Syversen, Sophia Ish-Shalom, Johan Halse

J Bone Miner Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis.
Harry K Genant, Johan Halse, Walter G Briney, Li Xie, Emmett V Glass

Curr Med Res Opin· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis